Literature DB >> 2123382

Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus.

H A van Steensel-Moll1, J A Hazelzet, E van der Voort, H J Neijens, W H Hackeng.   

Abstract

The association between infections with respiratory syncytial virus and plasma concentrations of antidiuretic hormone was assessed in 48 patients who had been admitted to hospital. The mean (SEM) concentration of antidiuretic hormone was significantly raised in patients with bronchiolitis (9.3 (1.4) ng/l) compared with non-pulmonary respiratory syncytial virus infections that cause apnoea or upper respiratory tract symptoms (6.1 (1.7) ng/l). The highest concentrations of antidiuretic hormone were seen in patients receiving mechanical ventilation (18.0 (6.7) ng/l). There were no differences in mean serum sodium concentrations among the subgroups. Hypertranslucency on chest radiograph or an arterial carbon dioxide tension above 6.67 kPa were associated with a significantly higher concentration of antidiuretic hormone. Increased or normal maintenance fluid intake in children with pulmonary respiratory syncytial virus infections may cause the same symptoms of fluid overload as the syndrome of inappropriate secretion of antidiuretic hormone. Patients with pulmonary respiratory syncytial virus infection, hypertranslucency in chest radiograph, hypercapnia, or mechanical ventilation are at risk for raised concentrations of antidiuretic hormone. Restricted fluid intake and careful monitoring of fluid balance and plasma electrolyte concentrations are therefore necessary in these patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123382      PMCID: PMC1792616          DOI: 10.1136/adc.65.11.1237

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Respiratory syncytial virus infections in children admitted to the intensive care unit.

Authors:  H A Van Steensel-Moll; E Van der Voort; A P Bos; P H Rothbarth; H J Neijens
Journal:  Pediatrie       Date:  1989

2.  Mechanical forces producing pulmonary edema in acute asthma.

Authors:  S A Stalcup; R B Mellins
Journal:  N Engl J Med       Date:  1977-09-15       Impact factor: 91.245

3.  Mechanical ventilation and respiratory syncytial virus infection.

Authors:  H A van Steensel-Moll; W J Tissing; M Offringa; J A Hazelzet
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

4.  Pneumonia and the syndrome of inappropriate antidiuretic hormone secretion: don't pour water on the fire.

Authors:  B S Dixon; R J Anderson
Journal:  Am Rev Respir Dis       Date:  1988-09

5.  Inappropriate secretion of antidiuretic hormone in infants with respiratory infections.

Authors:  R P Rivers; M L Forsling; R P Olver
Journal:  Arch Dis Child       Date:  1981-05       Impact factor: 3.791

6.  Acute infectious pneumonia is accompanied by a latent vasopressin-dependent impairment of renal water excretion.

Authors:  D Dreyfuss; F Leviel; M Paillard; J Rahmani; F Coste
Journal:  Am Rev Respir Dis       Date:  1988-09

7.  Antidiuretic hormone excess.

Authors:  A L Friedman; W E Segar
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

8.  [Plasma vasopressin in premature infants on mechanical ventilation].

Authors:  R Pomarède; G Moriette; P Czernichow; J P Relier
Journal:  Arch Fr Pediatr       Date:  1978-12

9.  The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease.

Authors:  B Volovitz; R C Welliver; G De Castro; D A Krystofik; P L Ogra
Journal:  Pediatr Res       Date:  1988-10       Impact factor: 3.756

10.  Pertussis complicated by the syndrome of inappropriate antidiuretic hormone secretion. Pathophysiology and management.

Authors:  P Matherne; J Matson; M I Marks
Journal:  Clin Pediatr (Phila)       Date:  1986-01       Impact factor: 1.168

View more
  18 in total

Review 1.  Evidence based treatment of bronchiolitis.

Authors:  G R Sethi; Gaurav Nagar
Journal:  Indian J Pediatr       Date:  2004-08       Impact factor: 1.967

2.  Lower airway disease caused by respiratory syncytial virus.

Authors:  R Aggarwal
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

3.  Home ventilation of a child with motor and sensory neuropathy. Study aims to set up national database of children receiving ventilatory support.

Authors:  E Jardine; C Wallis
Journal:  BMJ       Date:  1996-10-12

Review 4.  Management of acute bronchiolitis.

Authors:  K Rakshi; J M Couriel
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

5.  The neuroendocrine stress response and severity of acute respiratory syncytial virus bronchiolitis in infancy.

Authors:  Robert C Tasker; Michael F E Roe; David M Bloxham; Deborah K White; Robert I Ross-Russell; D Roddy O'Donnell
Journal:  Intensive Care Med       Date:  2004-11-06       Impact factor: 17.440

Review 6.  Advising patients to increase fluid intake for treating acute respiratory infections.

Authors:  Michelle Pb Guppy; Sharon M Mickan; Chris B Del Mar; Sarah Thorning; Alexander Rack
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

Review 7.  Bronchiolitis. Origins and optimal management.

Authors:  M L Everard
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

8.  Risk factors for mechanical ventilation in respiratory syncytial virus infection.

Authors:  W J Tissing; H A van Steensel-Moll; M Offringa
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

9.  Hyponatremic seizure associated with acute respiratory infection.

Authors:  Yoshitaka Iwazu; Sumiko Honma; Genro Fujisawa; Kiyoko Uki; Ichiro Yanaka; Yoshiaki Sato; Mitsunobu Murata; Eiji Kusano; Yasushi Asano
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

10.  Pilot safety study of low-dose vasopressin in non-septic critically ill children.

Authors:  Elisa Baldasso; Pedro Celiny Ramos Garcia; Jefferson Pedro Piva; Ricardo Garcia Branco; Robert Charles Tasker
Journal:  Intensive Care Med       Date:  2009-01-09       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.